Last10K.com

Aeterna Zentaris Inc. (AEZS) SEC Filing 6-K Foreign Issuer Report for the period ending Friday, June 30, 2023

Aeterna Zentaris Inc.

HISTORY TOOLS
CIK: 1113423 Ticker: AEZS

View differences made from one to another to evaluate Aeterna Zentaris Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aeterna Zentaris Inc..

Continue

Assess how Aeterna Zentaris Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aeterna Zentaris Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 6-K Foreign Issuer Report

Cover
Condensed Interim Consolidated Statements Of Cash Flows (Unaudited)
Condensed Interim Consolidated Statements Of Changes In Shareholders' Equity (Unaudited)
Condensed Interim Consolidated Statements Of Financial Position (Unaudited)
Condensed Interim Consolidated Statements Of Loss And Comprehensive Loss (Unaudited)
Basis Of Presentation
Basis Of Presentation (Policies)
Business Overview
Commitments
Commitments (Details Narrative)
Commitments (Tables)
Disclosure Of Changes In Operating Assets And Liabilities (Details)
Employee Future Benefits
Employee Future Benefits (Details Narrative)
Employee Future Benefits (Tables)
Net Loss Per Share
Net Loss Per Share (Tables)
Revenue
Revenue (Details Narrative)
Revenue (Tables)
Schedule Of Expected Future Minimum Lease Payments (Details)
Segment Information
Shareholders??? Equity
Shareholders??? Equity (Details Narrative)
Shareholders??? Equity (Tables)
Summary Of Assumptions To Determine Share-Based Compensation Costs Over The Life Of Awards (Details)
Summary Of Deferred Revenue (Details)
Summary Of Dsu Activity (Details)
Summary Of Net Defined Benefit Liability Asset (Details)
Summary Of Number And Weighted Average Exercise Prices Of Share Options (Details)
Summary Of Pertinent Data Relating To Computation Of Basic And Diluted Net Loss Per Share (Details)
Summary Of Revenue From Transfer Of Goods And Services (Details)
Summary Of Share Capital (Details)
Supplemental Disclosure Of Cash Flow Information
Supplemental Disclosure Of Cash Flow Information (Tables)

Material Contracts, Statements, Certifications & more

Aeterna Zentaris Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Exhibit 99.3: Additional Exhibits
Exhibit 99.4: Additional Exhibits
Ticker: AEZS
CIK: 1113423
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001493152-23-027263
Submitted to the SEC: Wed Aug 09 2023 8:05:31 AM EST
Accepted by the SEC: Wed Aug 09 2023
Period: Friday, June 30, 2023
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aezs/0001493152-23-027263.htm